Category: China
-
China’s top court overturns Nefecon generic PI despite U.S. Paragraph III-style no-launch pledge
A Chinese generic of Nefecon obtained formal approval after promising not to launch until patent expiry, then used that approval to seek procurement listings. China’s top court nevertheless held that the broken Paragraph III-style pledge was a regulatory breach – not an admission of patent infringement.
-
Align wins RMB 10M China injunction against Angelalign after UPC setback on related patent, parallel cases in injunction-tested Chinese venues
Align has won an injunction and RMB 10 million (approximately approximately $1.4 million) in damages against Angelalign in China, less than three months after the UPC refused provisional relief on a related European patent. The opposite outcomes add a new twist to their multi-jurisdictional patent fight.
-
China’s top court hands U.S. patentee landmark patent damages award
U.S. insecticide producer FMC Agriculture Singapore has been awarded a record of nearly 33 million Chinese yuan ($4.84 million) in patent infringement damages in a decision in which the defendant’s legal representative has also been found jointly liable – a rarity in Chinese IP infringement cases.
-
‘I am a latecomer’: former Xiaomi IP head Ran Xu on launching his own IP consultancy
Ran Xu talks to ip fray about where the idea to launch his consultancy, Rythan IP, came from, and why now was the ideal time to take the plunge.
-
China’s revised chip layout rules bring a patent-style revocation route, upfront identification of original features and punitive damages
China has created a patent-style CNIPA revocation route for chip layout-design disputes and introduced punitive damages of up to five times. The revised rules also require applicants to identify claimed original features and allow China to take countermeasures against discriminatory foreign restrictions on layout-design protection.
-
‘The future of medicine and diagnostics’: behind the patent enforcement strategy of biotech tools company Seer
Seer’s VP of Legal, George Fox, discusses the challenges that its patent portfolio has recently overcome, and the enforcement campaign it has launched in the U.S.
-
14 years of litigation, 28 days of breakthroughs: Apple contains a once-€1.2 billion Siri patent threat and advances its China AI rollout
Within 28 days, Apple won two first-instance judgments in its 14-year Siri patent dispute, in which Xiao-i had initially sought approximately €1.2 billion in damages, and Apple Intelligence completed filing with China’s cyberspace regulator. Behind that convergence lies a remarkable procedural history.
-
The CNIPA aligns China’s administrative SEP injunction standard with courts’ FRAND test
The CNIPA has made FRAND review a condition for administrative SEP cease-infringement orders, aligning the administrative approach with the judicial test. The clarification closes a gap in China’s dual-track patent enforcement system while CNIPA promotes greater use of administrative proceedings for SEP disputes.
-
China’s top court revives Maxeon BC solar patent in a rare patent validity reversal
A $238 million settlement ended Maxeon and Aiko’s European patent war—but not a Chinese validity fight affecting the same back-contact solar patent portfolio. China’s top court has now delivered Maxeon a rare reversal.